Adalimumab for corticosteroid and infliximab-resistant immune reconstitution inflammatory syndrome in the setting of TB/HIV coinfection

Nilar Lwin, Michael Boyle, Joshua S. Davis

Research output: Contribution to journalArticlepeer-review


Corticosteroids are the mainstay of therapy for immune reconstitution inflammatory syndrome (IRIS). However, little is known about how to treat IRIS unresponsive to steroids. We report a patient with HIV-TB coinfection who was unresponsive to first prednisolone and then infliximab but whose IRIS resolved with adalimumab.

Original languageEnglish
Article numberofy027
Pages (from-to)1-3
Number of pages3
JournalOpen Forum Infectious Diseases
Issue number2
Publication statusPublished - 1 Feb 2018

Cite this